Metal-based biologically active azoles and β-lactams derived from sulfa drugs
[Display omitted] Metal complexes of Schiff bases derived from sulfamethoxazole (SMZ) and sulfathiazole (STZ), converted to their β-lactam derivatives have been synthesized and experimentally characterized by elemental analysis, spectral (IR, 1H NMR, 13C NMR, and EI-mass), molar conductance measurem...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2016-03, Vol.24 (5), p.1121-1131 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1131 |
---|---|
container_issue | 5 |
container_start_page | 1121 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 24 |
creator | Ebrahimi, Hossein Pasha Hadi, Jabbar S. Almayah, Abdulelah A. Bolandnazar, Zeinab Swadi, Ali G. Ebrahimi, Amirpasha |
description | [Display omitted]
Metal complexes of Schiff bases derived from sulfamethoxazole (SMZ) and sulfathiazole (STZ), converted to their β-lactam derivatives have been synthesized and experimentally characterized by elemental analysis, spectral (IR, 1H NMR, 13C NMR, and EI-mass), molar conductance measurements and thermal analysis techniques. The structural and electronic properties of the studied molecules were investigated theoretically by performing density functional theory (DFT) to access reliable results to the experimental values. The spectral and thermal analysis reveals that the Schiff bases act as bidentate ligands via the coordination of azomethine nitrogen to metal ions as well as the proton displacement from the phenolic group through the metal ions; therefore, Cu complexes can attain the square planner arrangement and Zn complexes have a distorted tetrahedral structure. The thermogravimetric (TG/DTG) analyses confirm high stability for all complexes followed by thermal decomposition in different steps. In addition, the antibacterial activities of synthesized compounds have been screened in vitro against various pathogenic bacterial species. Inspection of the results revealed that all newly synthesized complexes individually exhibit varying degrees of inhibitory effects on the growth of the tested bacterial species, therefore, they may be considered as drug candidates for bacterial pathogens. The free Schiff base ligands (1–2) exhibited a broad spectrum antibacterial activity against Gram negative Escherichia coli, Pseudomonas aeruginosa, and Proteus spp., and Gram positive Staphylococcus aureus bacterial strains. The results also indicated that the β-lactam derivatives (3–4) have high antibacterial activities on Gram positive bacteria as well as the metal complexes (5–8), particularly Zn complexes, have a significant activity against all Gram negative bacterial strains. It has been shown that the metal complexes have significantly higher activity than corresponding ligands due to chelation process which reduces the polarity of metal ion by coordinating with ligands. |
doi_str_mv | 10.1016/j.bmc.2016.01.041 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790942100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089616300414</els_id><sourcerecordid>1765580872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-5dd1c1b8dd9c7203c5f52f85a2b00a2afcb0b32cf26616ae44527caeb86cb6a73</originalsourceid><addsrcrecordid>eNqNkMFO3TAQRa2qqLxCP6CbystuEsZO4jhihVChlYBuytoa2xPkJ-eF2gkSfFY_pN-E0aNdVl3NaObcuziMfRRQCxDqZFvbydWyrDWIGlrxhm1Eq9qqaQbxlm1gULoCPahD9j7nLQDIdhDv2KFUumlkKzfs5poWjJXFTJ7bMMf5LjiM8ZGjW8IDcXyaI2WOO89__6piueKUuadUnp6PaZ54XuOI3Kf1Lh-zgxFjpg-v84jdXnz5cf61uvp--e387KpyjVZL1XkvnLDa-8H1EhrXjZ0cdYfSAqDE0VmwjXSjVEoopLbtZO-QrFbOKuybI_Z533uf5p8r5cVMITuKEXc0r9mIfoChlQLgP1DVdRp0Lwsq9qhLc86JRnOfwoTp0QgwL8bN1hTj5sW4AWGK8ZL59Fq_2on838QfxQU43QNUfDwESia7QDtHPiRyi_Fz-Ef9M4BIkao</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765580872</pqid></control><display><type>article</type><title>Metal-based biologically active azoles and β-lactams derived from sulfa drugs</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ebrahimi, Hossein Pasha ; Hadi, Jabbar S. ; Almayah, Abdulelah A. ; Bolandnazar, Zeinab ; Swadi, Ali G. ; Ebrahimi, Amirpasha</creator><creatorcontrib>Ebrahimi, Hossein Pasha ; Hadi, Jabbar S. ; Almayah, Abdulelah A. ; Bolandnazar, Zeinab ; Swadi, Ali G. ; Ebrahimi, Amirpasha</creatorcontrib><description>[Display omitted]
Metal complexes of Schiff bases derived from sulfamethoxazole (SMZ) and sulfathiazole (STZ), converted to their β-lactam derivatives have been synthesized and experimentally characterized by elemental analysis, spectral (IR, 1H NMR, 13C NMR, and EI-mass), molar conductance measurements and thermal analysis techniques. The structural and electronic properties of the studied molecules were investigated theoretically by performing density functional theory (DFT) to access reliable results to the experimental values. The spectral and thermal analysis reveals that the Schiff bases act as bidentate ligands via the coordination of azomethine nitrogen to metal ions as well as the proton displacement from the phenolic group through the metal ions; therefore, Cu complexes can attain the square planner arrangement and Zn complexes have a distorted tetrahedral structure. The thermogravimetric (TG/DTG) analyses confirm high stability for all complexes followed by thermal decomposition in different steps. In addition, the antibacterial activities of synthesized compounds have been screened in vitro against various pathogenic bacterial species. Inspection of the results revealed that all newly synthesized complexes individually exhibit varying degrees of inhibitory effects on the growth of the tested bacterial species, therefore, they may be considered as drug candidates for bacterial pathogens. The free Schiff base ligands (1–2) exhibited a broad spectrum antibacterial activity against Gram negative Escherichia coli, Pseudomonas aeruginosa, and Proteus spp., and Gram positive Staphylococcus aureus bacterial strains. The results also indicated that the β-lactam derivatives (3–4) have high antibacterial activities on Gram positive bacteria as well as the metal complexes (5–8), particularly Zn complexes, have a significant activity against all Gram negative bacterial strains. It has been shown that the metal complexes have significantly higher activity than corresponding ligands due to chelation process which reduces the polarity of metal ion by coordinating with ligands.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2016.01.041</identifier><identifier>PMID: 26833242</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibacterial activity ; Azoles - chemistry ; Azoles - pharmacology ; Bacteria - drug effects ; Bacterial Infections - drug therapy ; beta-Lactams - chemistry ; beta-Lactams - pharmacology ; Coordination Complexes - chemistry ; Coordination Complexes - pharmacology ; Escherichia coli ; Humans ; Ligands ; Metal Schiff base ; Microbial Sensitivity Tests ; Models, Molecular ; NMR ; Pseudomonas aeruginosa ; Schiff Bases - chemistry ; Schiff Bases - pharmacology ; Staphylococcus aureus ; Sulfamethoxazole ; Sulfamethoxazole - analogs & derivatives ; Sulfamethoxazole - pharmacology ; Sulfathiazole ; Sulfathiazoles - chemistry ; Sulfathiazoles - pharmacology ; β-Lactam</subject><ispartof>Bioorganic & medicinal chemistry, 2016-03, Vol.24 (5), p.1121-1131</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-5dd1c1b8dd9c7203c5f52f85a2b00a2afcb0b32cf26616ae44527caeb86cb6a73</citedby><cites>FETCH-LOGICAL-c386t-5dd1c1b8dd9c7203c5f52f85a2b00a2afcb0b32cf26616ae44527caeb86cb6a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2016.01.041$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26833242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ebrahimi, Hossein Pasha</creatorcontrib><creatorcontrib>Hadi, Jabbar S.</creatorcontrib><creatorcontrib>Almayah, Abdulelah A.</creatorcontrib><creatorcontrib>Bolandnazar, Zeinab</creatorcontrib><creatorcontrib>Swadi, Ali G.</creatorcontrib><creatorcontrib>Ebrahimi, Amirpasha</creatorcontrib><title>Metal-based biologically active azoles and β-lactams derived from sulfa drugs</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted]
Metal complexes of Schiff bases derived from sulfamethoxazole (SMZ) and sulfathiazole (STZ), converted to their β-lactam derivatives have been synthesized and experimentally characterized by elemental analysis, spectral (IR, 1H NMR, 13C NMR, and EI-mass), molar conductance measurements and thermal analysis techniques. The structural and electronic properties of the studied molecules were investigated theoretically by performing density functional theory (DFT) to access reliable results to the experimental values. The spectral and thermal analysis reveals that the Schiff bases act as bidentate ligands via the coordination of azomethine nitrogen to metal ions as well as the proton displacement from the phenolic group through the metal ions; therefore, Cu complexes can attain the square planner arrangement and Zn complexes have a distorted tetrahedral structure. The thermogravimetric (TG/DTG) analyses confirm high stability for all complexes followed by thermal decomposition in different steps. In addition, the antibacterial activities of synthesized compounds have been screened in vitro against various pathogenic bacterial species. Inspection of the results revealed that all newly synthesized complexes individually exhibit varying degrees of inhibitory effects on the growth of the tested bacterial species, therefore, they may be considered as drug candidates for bacterial pathogens. The free Schiff base ligands (1–2) exhibited a broad spectrum antibacterial activity against Gram negative Escherichia coli, Pseudomonas aeruginosa, and Proteus spp., and Gram positive Staphylococcus aureus bacterial strains. The results also indicated that the β-lactam derivatives (3–4) have high antibacterial activities on Gram positive bacteria as well as the metal complexes (5–8), particularly Zn complexes, have a significant activity against all Gram negative bacterial strains. It has been shown that the metal complexes have significantly higher activity than corresponding ligands due to chelation process which reduces the polarity of metal ion by coordinating with ligands.</description><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial activity</subject><subject>Azoles - chemistry</subject><subject>Azoles - pharmacology</subject><subject>Bacteria - drug effects</subject><subject>Bacterial Infections - drug therapy</subject><subject>beta-Lactams - chemistry</subject><subject>beta-Lactams - pharmacology</subject><subject>Coordination Complexes - chemistry</subject><subject>Coordination Complexes - pharmacology</subject><subject>Escherichia coli</subject><subject>Humans</subject><subject>Ligands</subject><subject>Metal Schiff base</subject><subject>Microbial Sensitivity Tests</subject><subject>Models, Molecular</subject><subject>NMR</subject><subject>Pseudomonas aeruginosa</subject><subject>Schiff Bases - chemistry</subject><subject>Schiff Bases - pharmacology</subject><subject>Staphylococcus aureus</subject><subject>Sulfamethoxazole</subject><subject>Sulfamethoxazole - analogs & derivatives</subject><subject>Sulfamethoxazole - pharmacology</subject><subject>Sulfathiazole</subject><subject>Sulfathiazoles - chemistry</subject><subject>Sulfathiazoles - pharmacology</subject><subject>β-Lactam</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMFO3TAQRa2qqLxCP6CbystuEsZO4jhihVChlYBuytoa2xPkJ-eF2gkSfFY_pN-E0aNdVl3NaObcuziMfRRQCxDqZFvbydWyrDWIGlrxhm1Eq9qqaQbxlm1gULoCPahD9j7nLQDIdhDv2KFUumlkKzfs5poWjJXFTJ7bMMf5LjiM8ZGjW8IDcXyaI2WOO89__6piueKUuadUnp6PaZ54XuOI3Kf1Lh-zgxFjpg-v84jdXnz5cf61uvp--e387KpyjVZL1XkvnLDa-8H1EhrXjZ0cdYfSAqDE0VmwjXSjVEoopLbtZO-QrFbOKuybI_Z533uf5p8r5cVMITuKEXc0r9mIfoChlQLgP1DVdRp0Lwsq9qhLc86JRnOfwoTp0QgwL8bN1hTj5sW4AWGK8ZL59Fq_2on838QfxQU43QNUfDwESia7QDtHPiRyi_Fz-Ef9M4BIkao</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Ebrahimi, Hossein Pasha</creator><creator>Hadi, Jabbar S.</creator><creator>Almayah, Abdulelah A.</creator><creator>Bolandnazar, Zeinab</creator><creator>Swadi, Ali G.</creator><creator>Ebrahimi, Amirpasha</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20160301</creationdate><title>Metal-based biologically active azoles and β-lactams derived from sulfa drugs</title><author>Ebrahimi, Hossein Pasha ; Hadi, Jabbar S. ; Almayah, Abdulelah A. ; Bolandnazar, Zeinab ; Swadi, Ali G. ; Ebrahimi, Amirpasha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-5dd1c1b8dd9c7203c5f52f85a2b00a2afcb0b32cf26616ae44527caeb86cb6a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial activity</topic><topic>Azoles - chemistry</topic><topic>Azoles - pharmacology</topic><topic>Bacteria - drug effects</topic><topic>Bacterial Infections - drug therapy</topic><topic>beta-Lactams - chemistry</topic><topic>beta-Lactams - pharmacology</topic><topic>Coordination Complexes - chemistry</topic><topic>Coordination Complexes - pharmacology</topic><topic>Escherichia coli</topic><topic>Humans</topic><topic>Ligands</topic><topic>Metal Schiff base</topic><topic>Microbial Sensitivity Tests</topic><topic>Models, Molecular</topic><topic>NMR</topic><topic>Pseudomonas aeruginosa</topic><topic>Schiff Bases - chemistry</topic><topic>Schiff Bases - pharmacology</topic><topic>Staphylococcus aureus</topic><topic>Sulfamethoxazole</topic><topic>Sulfamethoxazole - analogs & derivatives</topic><topic>Sulfamethoxazole - pharmacology</topic><topic>Sulfathiazole</topic><topic>Sulfathiazoles - chemistry</topic><topic>Sulfathiazoles - pharmacology</topic><topic>β-Lactam</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ebrahimi, Hossein Pasha</creatorcontrib><creatorcontrib>Hadi, Jabbar S.</creatorcontrib><creatorcontrib>Almayah, Abdulelah A.</creatorcontrib><creatorcontrib>Bolandnazar, Zeinab</creatorcontrib><creatorcontrib>Swadi, Ali G.</creatorcontrib><creatorcontrib>Ebrahimi, Amirpasha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ebrahimi, Hossein Pasha</au><au>Hadi, Jabbar S.</au><au>Almayah, Abdulelah A.</au><au>Bolandnazar, Zeinab</au><au>Swadi, Ali G.</au><au>Ebrahimi, Amirpasha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metal-based biologically active azoles and β-lactams derived from sulfa drugs</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>24</volume><issue>5</issue><spage>1121</spage><epage>1131</epage><pages>1121-1131</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted]
Metal complexes of Schiff bases derived from sulfamethoxazole (SMZ) and sulfathiazole (STZ), converted to their β-lactam derivatives have been synthesized and experimentally characterized by elemental analysis, spectral (IR, 1H NMR, 13C NMR, and EI-mass), molar conductance measurements and thermal analysis techniques. The structural and electronic properties of the studied molecules were investigated theoretically by performing density functional theory (DFT) to access reliable results to the experimental values. The spectral and thermal analysis reveals that the Schiff bases act as bidentate ligands via the coordination of azomethine nitrogen to metal ions as well as the proton displacement from the phenolic group through the metal ions; therefore, Cu complexes can attain the square planner arrangement and Zn complexes have a distorted tetrahedral structure. The thermogravimetric (TG/DTG) analyses confirm high stability for all complexes followed by thermal decomposition in different steps. In addition, the antibacterial activities of synthesized compounds have been screened in vitro against various pathogenic bacterial species. Inspection of the results revealed that all newly synthesized complexes individually exhibit varying degrees of inhibitory effects on the growth of the tested bacterial species, therefore, they may be considered as drug candidates for bacterial pathogens. The free Schiff base ligands (1–2) exhibited a broad spectrum antibacterial activity against Gram negative Escherichia coli, Pseudomonas aeruginosa, and Proteus spp., and Gram positive Staphylococcus aureus bacterial strains. The results also indicated that the β-lactam derivatives (3–4) have high antibacterial activities on Gram positive bacteria as well as the metal complexes (5–8), particularly Zn complexes, have a significant activity against all Gram negative bacterial strains. It has been shown that the metal complexes have significantly higher activity than corresponding ligands due to chelation process which reduces the polarity of metal ion by coordinating with ligands.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26833242</pmid><doi>10.1016/j.bmc.2016.01.041</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2016-03, Vol.24 (5), p.1121-1131 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_proquest_miscellaneous_1790942100 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibacterial activity Azoles - chemistry Azoles - pharmacology Bacteria - drug effects Bacterial Infections - drug therapy beta-Lactams - chemistry beta-Lactams - pharmacology Coordination Complexes - chemistry Coordination Complexes - pharmacology Escherichia coli Humans Ligands Metal Schiff base Microbial Sensitivity Tests Models, Molecular NMR Pseudomonas aeruginosa Schiff Bases - chemistry Schiff Bases - pharmacology Staphylococcus aureus Sulfamethoxazole Sulfamethoxazole - analogs & derivatives Sulfamethoxazole - pharmacology Sulfathiazole Sulfathiazoles - chemistry Sulfathiazoles - pharmacology β-Lactam |
title | Metal-based biologically active azoles and β-lactams derived from sulfa drugs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metal-based%20biologically%20active%20azoles%20and%20%CE%B2-lactams%20derived%20from%20sulfa%20drugs&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Ebrahimi,%20Hossein%20Pasha&rft.date=2016-03-01&rft.volume=24&rft.issue=5&rft.spage=1121&rft.epage=1131&rft.pages=1121-1131&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2016.01.041&rft_dat=%3Cproquest_cross%3E1765580872%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1765580872&rft_id=info:pmid/26833242&rft_els_id=S0968089616300414&rfr_iscdi=true |